Phastar
Phastar is a global biometrics contract research organization specializing in data solutions, biostatistics, programming, data management, and data science. Committed to quality, innovation, and client-centric approaches, they support pharmaceutical, biotech, and medical device companies worldwide to accelerate drug development, ensure compliance, and improve human health through advanced analytics, regulatory support, and strategic partnerships.
Industries
Nr. of Employees
large (251-1000)
Phastar
UK HQ: 2D Bollo Ln, Chiswick, London, W4 5LE
Products
Integrated clinical monitoring and analytics platform
A centralised platform that consolidates operational, clinical and audit data into interactive dashboards, visualisations and traceable audit trails to support review, oversight and submission readiness.
Integrated clinical monitoring and analytics platform
A centralised platform that consolidates operational, clinical and audit data into interactive dashboards, visualisations and traceable audit trails to support review, oversight and submission readiness.
Services
End‑to‑end statistical advice for study design, estimand definition, analysis planning, simulations and interpretation tailored to regulatory requirements.
Reproducible programming deliverables including analysis datasets, tables, listings and figures for clinical study reports and regulatory submission.
Design and operation of data capture, cleaning and review processes with integration to common EDC systems and audit‑ready documentation.
Machine learning, predictive modelling, simulation and bespoke analytics to inform recruitment, risk monitoring and decision support.
Design, simulation and delivery support for adaptive and Bayesian trials including prior elicitation, interim decision rules and regulatory rationale.
Preparation of submission documentation, statistical outputs and support for regulator interactions and responses.
End‑to‑end statistical advice for study design, estimand definition, analysis planning, simulations and interpretation tailored to regulatory requirements.
Reproducible programming deliverables including analysis datasets, tables, listings and figures for clinical study reports and regulatory submission.
Design and operation of data capture, cleaning and review processes with integration to common EDC systems and audit‑ready documentation.
Machine learning, predictive modelling, simulation and bespoke analytics to inform recruitment, risk monitoring and decision support.
Design, simulation and delivery support for adaptive and Bayesian trials including prior elicitation, interim decision rules and regulatory rationale.
Preparation of submission documentation, statistical outputs and support for regulator interactions and responses.
Expertise Areas
- Clinical trial design and analysis
- Biostatistics and statistical consulting
- Biostatistical programming
- Clinical data management
Key Technologies
- Bayesian statistics and prior elicitation
- Adaptive trial design and simulation
- Model‑based recursive partitioning (MOB)
- PALM trees (GLM tree methods)
News & Updates
Join Phastar at the Statistics and Biopharmacy Conference in Paris, France, from 8th – 10th October 2025.
Join Phastar at the Bay Area Biotech-Pharma Statistics Workshop in Foster City, CA, from November 6th – 7th.
Support sponsor at the 2025 ASA Biopharmaceutical Workshop from September 24th – 25th.
Explores outsourcing challenges facing biotechs, opportunities for collaboration, and tips for partner selection.
Discusses key factors for selecting CRO partners in biotech clinical development.
Highlights the importance of strategic partnerships in biotech development.
Join Phastar at the Statistics and Biopharmacy Conference in Paris, France, from 8th – 10th October 2025.
Join Phastar at the Bay Area Biotech-Pharma Statistics Workshop in Foster City, CA, from November 6th – 7th.
Support sponsor at the 2025 ASA Biopharmaceutical Workshop from September 24th – 25th.
Explores outsourcing challenges facing biotechs, opportunities for collaboration, and tips for partner selection.
Discusses key factors for selecting CRO partners in biotech clinical development.
Highlights the importance of strategic partnerships in biotech development.